Cancer Drugs Reversing Alzheimer's Brain Changes in Mice Show Promise
TL;DR Summary
US researchers used computational analysis to identify two FDA-approved cancer drugs, letrozole and irinotecan, that counteract Alzheimer’s-related gene-expression changes. In mouse models, when used together they reduced tau protein clumps and improved learning and memory, suggesting potential for repurposing and faster clinical testing, though safety in humans and side effects must be evaluated before any trials for Alzheimer's.
- Scientists Found 2 Existing Drugs Could Reverse Alzheimer's Brain Damage in Mice ScienceAlert
- New drug could slow the development of Alzheimer’s ETH Zürich
- New Compound Blocks Nerve Cell Death in Alzheimer’s Neuroscience News
- A Single Enzyme Gone Rogue May Drive Alzheimer’s, and One Molecule Can Calm It Down ScienceBlog.com
- Researchers Target GRK2 To Slow Neurodegeneration in Alzheimer’s Models Technology Networks
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
4 min
vs 5 min read
Condensed
93%
836 → 58 words
Want the full story? Read the original article
Read on ScienceAlert